name

王仲春

sex

age

57 岁

hospital number

045200

height

170 cm

weight

60 kg

BSA

1.65 m2

APACHEⅡ

20 分

Infection source

date

2017/4/14 年/月/日

Sequential Organ Failure Assessment

15 分

Fluid resuscitation

age>=60

septic shock

mechanical ventilation

Early fluid resuscitation

age<60

Pregnant woman

advanced malignant tumor

Pulmonary interstitial fibrosis

Serious arrhythmia

Small Tidal Volume Ventilation

Liver failure

Refuse to participate

Heart disease

米卡芬净100mgQD，斯沃0.6gQ12H

vasoactive agent

30 min

30 min

30 min

Temperature

38.6 ℃

Heart Rate

128 次/分

Breath

25 次/分

Systolic pressure (SP)

109 mmHg

Diastolic pressure

56 mmHg

mean arterial pressure

71 mmHg

Pcv-aCO2

10 mmHg

DO2

349.9

VO2

116.6

Ca-vO2

33.8

pH value

7.25

PaO2

39 mmHg

PaCO2

63 mmHg

BE

-0.4 mmol/L(±2.3mmol/L)

SaO2

63 %

Blood lactic acid concentration, LAC

4.2 mmol/L

Oxygenation index (PaO2/FiO2)

39 mmHg

pH value

7.23

PcvO2

29 mmHg

PcvCO2

73 mmHg

BE

1.6 mmol/L

ScvO2

42 %

Volume of input

0 ml

Volume of output

0 ml

Volume of urine

0 ml

ultrafiltration volume

0 ml

norepinephrine

Norepinephrine Dosage

0.45 μg/Kg/min

dopamine

Dopamine Dosage

0 μg/Kg/min

Dobutamine

Dobutamine Dosage

0 μg/Kg/min

CVP

11 mmHg

cardiac output

3.45 L/min

cardiac index

1.91 L/min/m2

stroke volume

27 ml

Stroke Index

14.9 ml/m2

ITBVI

831 ml/m2

GEDVI

665 ml/m2

EVLWI

13.6 ml/kg

PVPI

3.0

SVRI

2517 DSm2/cm5

CFI

3

GEF

9 %

SVV

24 %

PPV

%

dPmax

1155

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

the number of B line

条

LUS

分

B+ Zone

区

IVC(inspiratory phase)

mm

IVC(expiratory phase)

mm

respiratory variations of inferior vena cavae diameter

%

mm

mm

mm

mm

Temperature

37.8 ℃

Heart Rate

135 次/分

Breath

27 次/分

Systolic Pressure

153 mmHg

Diastolic Pressure

64 mmHg

Mean Arterial Pressure

88 mmHg

Pcv-aCO2

18 mmHg

DO2

384.4

VO2

201.3

Ca-vO2

53.1

PH value

7.14

PaO2

44 mmHg

PaCO2

63 mmHg

BE

-8.3 mmol/L

SaO2

63 %

Blood Lactic Acid Concentration

4.7 mmol/L

Oxygenation index (PaO2/FiO2)

44 mmHg

PH value

7.09

PcvO2

28 mmHg

PcvCO2

81 mmHg

BE

-7.4 mmol/L

ScvO2

30 %

Volume of input

2531 ml

Volume of output

100 ml

Volume of urine

50 ml

Ultrafiltration Volume

0 ml

Norepinephrine Dosage

6 mg

Dopamine Dosage

0 mg

Epinephrine Dosage

0 mg

Pituitrin Dosage

0 U

Dobutamine Dosage

0 mg

Milrinone Dosage

0 mg

Levosimendan

CVP

12 mmHg

cardiac output

3.79 L/min

cardiac index

2.09 L/min/m2

stroke volume

28.1 ml

Stroke Index

15.5 ml/m2

ITBVI

909 ml/m2

GEDVI

727 ml/m2

EVLWI

22.1 ml/kg

PVPI

4.8

SVRI

2902 DSm2/cm5

CFI

3

GEF

9 %

SVV

12 %

PPV

%

dPmax

2112

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

The number of B line

条

LUS

分

B+ Zone

区

IVC(inspiratory phase)

mm

IVC(expiratory phase)

mm

Respiratory variations of inferior vena cavae diameter

%

mm

mm

mm

mm

Temperature

36.8 ℃

Heart Rate

114 次/分

Breath

20 次/分

Systolic Pressure

154 mmHg

Diastolic Pressure

60 mmHg

Mean Arterial Pressure

95 mmHg

Pcv-aCO2

9 mmHg

DO2

891.6

VO2

411.4

Ca-vO2

57.9

PH value

7.25

PaO2

50 mmHg

PaCO2

55 mmHg

BE

-3.8 mmol/L

SaO2

78 %

Blood Lactic Acid Concentration

2.6 mmol/L

Oxygenation index (PaO2/FiO2)

50 mmHg

PH value

7.18

PcvO2

31 mmHg

PcvCO2

64 mmHg

BE

-5.4 mmol/L

ScvO2

42 %

Volume of input

5035 ml

Volume of output

450 ml

Volume of urine

300 ml

Ultrafiltration Volume

0 ml

Norepinephrine Dosage

60 mg

Dopamine Dosage

0 mg

Epinephrine Dosage

0 mg

Pituitrin Dosage

0 U

Dobutamine Dosage

0 mg

Milrinone Dosage

0 mg

Levosimendan

CVP

20 mmHg

cardiac output

7.1 L/min

cardiac index

3.92 L/min/m2

stroke volume

62.3 ml

Stroke Index

34.4 ml/m2

ITBVI

1155 ml/m2

GEDVI

924 ml/m2

EVLWI

26.6 ml/kg

PVPI

4.4

SVRI

1529 DSm2/cm5

CFI

4

GEF

15 %

SVV

10 %

PPV

%

dPmax

2219

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

The number of B line

条

LUS

分

B+ Zone

区

IVC(inspiratory phase)

mm

IVC(expiratory phase)

mm

Respiratory variations of inferior vena cavae diameter

%

mm

mm

mm

mm

Temperature

38.5 ℃

Heart Rate

129 次/分

Breath

26 次/分

Systolic Pressure

98 mmHg

Diastolic Pressure

43 mmHg

Mean Arterial Pressure

56 mmHg

Pcv-aCO2

17 mmHg

DO2

368.6

VO2

168.4

Ca-vO2

53.1

PH value

7.37

PaO2

47 mmHg

PaCO2

38 mmHg

BE

-3.0 mmol/L

SaO2

81 %

Blood Lactic Acid Concentration

2.7 mmol/L

Oxygenation index (PaO2/FiO2)

47 mmHg

PH value

7.29

PcvO2

28 mmHg

PcvCO2

55 mmHg

BE

-0.8 mmol/L

ScvO2

44 %

Volume of input

6575 ml

Volume of output

920 ml

Volume of urine

350 ml

Ultrafiltration Volume

420 ml

Norepinephrine Dosage

140 mg

Dopamine Dosage

0 mg

Epinephrine Dosage

0 mg

Pituitrin Dosage

0 U

Dobutamine Dosage

0 mg

Milrinone Dosage

0 mg

Levosimendan

CVP

11 mmHg

cardiac output

3.17 L/min

cardiac index

1.75 L/min/m2

stroke volume

24.6 ml

Stroke Index

13.6 ml/m2

ITBVI

736 ml/m2

GEDVI

589 ml/m2

EVLWI

29.3 ml/kg

PVPI

7.7

SVRI

2146 DSm2/cm5

CFI

3

GEF

10 %

SVV

21 %

PPV

%

dPmax

1573

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

The number of B line

条

LUS

分

B+ Zone

区

IVC(inspiratory phase)

mm

IVC(expiratory phase)

mm

Respiratory variations of inferior vena cavae diameter

%

mm

mm

mm

mm

Temperature

℃

Heart Rate

次/分

Breath

次/分

Systolic Pressure

mmHg

Diastolic Pressure

mmHg

Mean Arterial Pressure

mmHg

Pcv-aCO2

mmHg

DO2

VO2

Ca-vO2

PH value

PaO2

mmHg

PaCO2

mmHg

BE

mmol/L

SaO2

%

Blood Lactic Acid Concentration

mmol/L

Oxygenation index (PaO2/FiO2)

mmHg

PH value

PcvO2

mmHg

PcvCO2

mmHg

BE

mmol/L

ScvO2

%

Volume of input

ml

Volume of output

ml

Volume of urine

ml

Ultrafiltration Volume

ml

Norepinephrine Dosage

mg

Dopamine Dosage

mg

Epinephrine Dosage

mg

Pituitrin Dosage

U

Dobutamine Dosage

mg

Milrinone Dosage

mg

Levosimendan

CVP

mmHg

cardiac output

L/min

cardiac index

L/min/m2

stroke volume

ml

Stroke Index

ml/m2

ITBVI

ml/m2

GEDVI

ml/m2

EVLWI

ml/kg

PVPI

SVRI

DSm2/cm5

CFI

GEF

%

SVV

%

PPV

%

dPmax

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

The number of B line

条

LUS

分

B+ Zone

区

IVC(inspiratory phase)

mm

IVC(expiratory phase)

mm

Respiratory variations of inferior vena cavae diameter

%

mm

mm

mm

mm

Temperature

℃

Heart Rate

次/分

Breath

次/分

Systolic Pressure

mmHg

Diastolic Pressure

mmHg

Mean Arterial Pressure

mmHg

Pcv-aCO2

mmHg

DO2

VO2

Ca-vO2

PH value

PaO2

mmHg

PaCO2

mmHg

BE

mmol/L

SaO2

%

Blood Lactic Acid Concentration

mmol/L

Oxygenation index (PaO2/FiO2)

mmHg

PH value

PcvO2

mmHg

PcvCO2

mmHg

BE

mmol/L

ScvO2

%

Volume of input

ml

Volume of output

ml

Volume of urine

ml

Ultrafiltration Volume

ml

Norepinephrine Dosage

mg

Dopamine Dosage

mg

Epinephrine Dosage

mg

Pituitrin Dosage

U

Dobutamine Dosage

mg

Milrinone Dosage

mg

Levosimendan

CVP

mmHg

cardiac output

L/min

cardiac index

L/min/m2

stroke volume

ml

Stroke Index

ml/m2

ITBVI

ml/m2

GEDVI

ml/m2

EVLWI

ml/kg

PVPI

SVRI

DSm2/cm5

CFI

GEF

%

SVV

%

PPV

%

dPmax

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

The number of B line

条

LUS

分

B+ Zone

区

IVC(expiratory phase)

mm

Respiratory variations of inferior vena cavae diameter

%

IVC(inspiratory phase)

mm

mm

mm

mm

mm

NT-proBNP

pg/ml

BNP

1040 pg/ml

cTNI

0.257 ng/ml

Creatine kinase isoenzyme, CKMB

34.96 U/L

Creatinine

99 umol/L

Urea nitrogen

5 mmol/l

MDRD

59.3 ml/min/1.73m2

Date of examination

2017/4/14 yyyy-mm-dd

WBC

2.4 X10*9/L

neutrophilic granulocyte percentage

91 %

Hb

120 g/L

CRP

169 mg/L

Procalcitonin, PCT

25.5 ng/ml

Date of test

2017/4/14

Sequential Organ Failure Assessment

15 分

NT-proBNP

pg/ml

BNP

2170 pg/ml

cTNI

0.907 ng/ml

Creatine kinase isoenzyme, CKMB

29.9 U/L

Creatinine

119.84 umol/L

Urea nitrogen

5.99 mmol/l

MDRD

50.4 ml/min/1.73m2

WBC

3.9 X10*9/L

neutrophilic granulocyte percentage

94.5 %

Hb

107 g/L

CRP

144.22 mg/L

Procalcitonin, PCT

ng/ml

Sequential Organ Failure Assessment

17 分

NT-proBNP

pg/ml

BNP

pg/ml

cTNI

ng/ml

Creatine kinase isoenzyme, CKMB

U/L

Creatinine

umol/L

Urea nitrogen

mmol/L

MDRD

ml/min/1.73m2

WBC

X10*9/L

neutrophilic granulocyte percentage

%

Hb

g/L

CRP

mg/L

Procalcitonin, PCT

ng/ml

Sequential Organ Failure Assessment

分

Transfusion of Red Cells

Transfusion of Red Cells

2 U

Plasma infusion

Plasma infusion

200 ml

platelet transfusion

platelet transfusion

0 U

APACHEⅡ

20 分

Complication

prognosis

28-day mortality

survival time(day)

4 天

death time

2017/4/16 yyyy/mm/dd

diagnosis of death

多脏衰

length of stay

4 天

duration in ICU

4 天

duration of mechanical ventilation

70 小时

ICU expenses

26789 元

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy

10 小时